Fibroblast growth factor receptors across urothelial carcinoma landscape.

Ertl, Iris E; Shariat, Shahrokh F; Mostafaei, Hadi; Ilijazi, Dafina; Loriot, Yohann

Ertl, Iris E; Shariat, Shahrokh F; Mostafaei, Hadi; Ilijazi, Dafina; Loriot, Yohann.

Affiliation

Ertl IE; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Mostafaei H; Department of Urology, Weill Cornell Medical College, New York, USA.
Ilijazi D; Department of Urology, University of Texas Southwestern, Dallas, Texas, USA.
Loriot Y; Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic.

Curr Opin Urol ; 30(4): 557-565, 2020 07.

Article in En | MEDLINE | ID: mdl-32452999

Subject(s)

Antineoplastic Agents/therapeutic use; Carcinoma, Transitional Cell/drug therapy; Protein Kinase Inhibitors/therapeutic use; Pyrazoles/therapeutic use; Quinoxalines/therapeutic use; Receptors, Fibroblast Growth Factor/therapeutic use; Urinary Bladder Neoplasms/drug therapy; Urologic Neoplasms/drug therapy; Carcinoma, Transitional Cell/pathology; Humans; Neoplasm Recurrence, Local; Receptor, Fibroblast Growth Factor, Type 3; Receptors, Fibroblast Growth Factor/antagonists & inhibitors; Treatment Outcome; Urinary Bladder Neoplasms/pathology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Quinoxalines / Urinary Bladder Neoplasms / Carcinoma, Transitional Cell / Urologic Neoplasms / Receptors, Fibroblast Growth Factor / Protein Kinase Inhibitors / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: Curr Opin Urol Journal subject: UROLOGIA Year: 2020 Type: Article Affiliation country: Austria

Fulltext

XML

PubMed Links

Search on Google